Myriad Genetics
MYGN
#6699
Rank
NZ$1.14 B
Marketcap
NZ$12.31
Share price
-3.27%
Change (1 day)
-55.74%
Change (1 year)

Myriad Genetics (MYGN) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$0.61 Billion

According to Myriad Genetics's latest financial reports the company's total liabilities are NZ$0.61 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Myriad Genetics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$0.57 B0.77%
2023-12-31NZ$0.57 B16.57%
2022-12-31NZ$0.49 B-4.61%
2021-12-31NZ$0.51 B
2020-06-30NZ$0.75 B6.99%
2019-06-30NZ$0.70 B128.13%
2018-06-30NZ$0.30 B-48.7%
2017-06-30NZ$0.60 B224.6%
2016-06-30NZ$0.18 B20.96%
2015-06-30NZ$0.15 B28.25%
2014-06-30NZ$0.11 B23.01%
2013-06-30NZ$97.22 M41.92%
2012-06-30NZ$68.5 M28.87%
2011-06-30NZ$53.15 M1.39%
2010-06-30NZ$52.42 M4.49%
2009-06-30NZ$50.17 M-48.2%
2008-06-30NZ$96.85 M111.67%
2007-06-30NZ$45.75 M3.32%
2006-06-30NZ$44.28 M30.09%
2005-06-30NZ$34.04 M44.39%
2004-06-30NZ$23.57 M-29.01%
2003-06-30NZ$33.21 M-43.4%
2002-06-30NZ$58.68 M-26.78%
2001-06-30NZ$80.14 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Bio-Rad Laboratories
BIO
NZ$5.13 B 732.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
NZ$5.90 B 856.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
NZ$37.87 M-93.86%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$2.70 B 338.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$57.14 B 9,164.57%๐Ÿ‡บ๐Ÿ‡ธ USA